Pharma Mirror

MAY 8, 2021

Perigord announces the release of GLAMS 5.0, the latest update to its industry-leading AMS platform. Developed to the specific needs of the Life Science industry, this latest release boasts an expanded suite of both new and improved features, as well as greatly improved performance. GLAMS 5’s new deep search capabilities break down potential impediments to getting products to market, and allows users to create deep and wide-ranging searches of all their artwork data, including querying active te

Life Science 130

Life Science Production Marketing Development 130

Drug Patent Watch

MAY 8, 2021

Annual Drug Patent Expirations for TARCEVA Tarceva is a drug marketed by Osi Pharms and is included in one NDA. It is available from one supplier. There are two patents…. The post New patent expiration for Osi Pharms drug TARCEVA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98

Drugs Marketing 98

Scienmag

MAY 8, 2021

ESMO Breast Cancer 2021 Virtual Congress, 5-8 May Credit: ESMO Lugano, Switzerland, 8 May 2021 – The finding that breast tumours can evolve to express low HER2 potentially widens the number of patients who can benefit from new investigational agents, typically novel antibody-drug conjugate therapies, that are currently in clinical trials for HER2-low tumours.

Clinical Trials 67

Clinical Trials Clinical Trials Antibody Trials 67

The Pharma Data

MAY 8, 2021

Sandoz, a Novartis division, today announced progress in the late-stage clinical development program for its proposed biosimilar aflibercept. Sandoz will begin enrolling the first patient in MYLIGHT, a clinical Phase III confirmatory efficacy and safety study, shortly 1. Aflibercept is indicated to improve visual acuity in patients with neovascular age-related macular degeneration (nAMD), diabetic macular oedema, macular oedema secondary to retinal vein occlusion, and other specific neovascular

Clinical Development 52

Clinical Development Medicine Development Containment 52

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

Scienmag

MAY 8, 2021

The first global review of complementary medicines (herbal and dietary supplements) for weight loss in 16 years–combining 121 randomised placebo-controlled trials including nearly 10,000 adults–suggests that their use cannot be justified based on the current evidence. The findings of two studies, being presented at The European Congress on Obesity (ECO) held online this year, suggest […].

Medicine 73

Medicine Trials 73

BioTech 365

MAY 8, 2021

Datopotamab Deruxtecan Late-Breaking Data at ESMO Breast Shows Promising Preliminary Response and Disease Control in Patients with Metastatic Triple Negative Breast Cancer Datopotamab Deruxtecan Late-Breaking Data at ESMO Breast Shows Promising Preliminary Response and Disease Control in Patients with Metastatic … Continue reading →

52

52

BioTech 365

MAY 8, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Daiichi Sankyo, AstraZeneca’s $5B Enhertu follow-up shows early signs of success in breast cancer.

Research 40

Research 40

Scienmag

MAY 8, 2021

A complicated interaction between different proteins is needed for information to pass from one nerve cell to the next. Researchers at the Martin Luther University Halle-Wittenberg (MLU) have now managed to study this process in the synaptic vesicles, which play an important role in this process. The study appeared in the journal Nature Communications.

Protein 67

Protein Research 67

Drug Patent Watch

MAY 8, 2021

This chart shows the pharmaceutical companies with the most patents in Sweden. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Sweden? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs 52

Scienmag

MAY 8, 2021

Researchers provide reassuring findings to the majority who have had COVID-19 Mild Covid-19 infection is very unlikely to cause lasting damage to the structure or function of the heart, according to a study led by UCL (University College London) researchers and funded by the British Heart Foundation (BHF) and Barts Charity. The researchers say the […].

Research 59

Research Cardiology Medicine 59

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

The Pharma Data

MAY 8, 2021

Johnson & Johnson (NYSE: JNJ) (the Company) today announced that vaccinations with the Company’s COVID-19 single-shot vaccine will resume for all adults aged 18 years and older in the U.S., under Emergency Use Authorization (EUA), following a decision from the United States Centers for Disease Control (CDC) and Food and Drug Administration (FDA).

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

Scienmag

MAY 8, 2021

Vegetarians appear to have a healthier biomarker profile than meat-eaters, and this applies to adults of any age and weight, and is also unaffected by smoking and alcohol consumption, according to a new study in over 166,000 UK adults, being presented at this week’s European Congress on Obesity (ECO), held online this year. Biomarkers can […].

Medicine 49

Medicine 49